Headlines

IDEXX Laboratories Inc. (IDXX) Q4 2025 (USD): EPS 3.08 (exp. 2.93), Revenue 1.09bln (exp. 1.07bln); revenue outlook for 2026 in the range of 4.63-4.72bln (exp. 4.66bln)

Newsquawk Staff ·

IDEXX Laboratories Inc. (IDXX) Q4 2025 (USD): EPS 3.08 (exp. 2.93), Revenue 1.09bln (exp. 1.07bln); revenue outlook for 2026 in the range of 4.63-4.72bln (exp. 4.66bln)

What it means

IDEXX Laboratories reported stronger-than-expected earnings for Q4 2025, with EPS and revenue both exceeding analyst estimates. This positive performance, alongside a solid revenue outlook for 2026 that aligns closely with expectations, suggests robust operational strength, potentially bolstering investor confidence in the healthcare sector and possibly influencing sector peers and market sentiment.

Related headlines